Literature DB >> 33398179

Memory-like HCV-specific CD8+ T cells retain a molecular scar after cure of chronic HCV infection.

Nina Hensel1,2,3, Zuguang Gu4, Dominik Wieland1,2, Katharina Jechow5, Janine Kemming1,2,3, Sian Llewellyn-Lacey6, Emma Gostick6, Oezlem Sogukpinar1,2, Florian Emmerich2,7, David A Price6,8, Bertram Bengsch1,2,9, Tobias Boettler1,2, Christoph Neumann-Haefelin1,2, Roland Eils5,10, Christian Conrad5, Ralf Bartenschlager11,12,13, Dominic Grün14,9, Naveed Ishaque5, Robert Thimme15,16, Maike Hofmann17,18.   

Abstract

In chronic hepatitis C virus (HCV) infection, exhausted HCV-specific CD8+ T cells comprise memory-like and terminally exhausted subsets. However, little is known about the molecular profile and fate of these two subsets after the elimination of chronic antigen stimulation by direct-acting antiviral (DAA) therapy. Here, we report a progenitor-progeny relationship between memory-like and terminally exhausted HCV-specific CD8+ T cells via an intermediate subset. Single-cell transcriptomics implicated that memory-like cells are maintained and terminally exhausted cells are lost after DAA-mediated cure, resulting in a memory polarization of the overall HCV-specific CD8+ T cell response. However, an exhausted core signature of memory-like CD8+ T cells was still detectable, including, to a smaller extent, in HCV-specific CD8+ T cells targeting variant epitopes. These results identify a molecular signature of T cell exhaustion that is maintained as a chronic scar in HCV-specific CD8+ T cells even after the cessation of chronic antigen stimulation.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33398179     DOI: 10.1038/s41590-020-00817-w

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  51 in total

1.  Role of maternal functioning and parenting skills in adolescent functioning following parental divorce.

Authors:  R Forehand; A M Thomas; M Wierson; G Brody; R Fauber
Journal:  J Abnorm Psychol       Date:  1990-08

Review 2.  CD8 T Cell Exhaustion During Chronic Viral Infection and Cancer.

Authors:  Laura M McLane; Mohamed S Abdel-Hakeem; E John Wherry
Journal:  Annu Rev Immunol       Date:  2019-01-24       Impact factor: 28.527

3.  Aspartate transcarbamylase. Studies of the catalytic subunit by ultraviolet difference spectroscopy.

Authors:  K D Collins; G R Stark
Journal:  J Biol Chem       Date:  1969-04-10       Impact factor: 5.157

Review 4.  Defining 'T cell exhaustion'.

Authors:  Christian U Blank; W Nicholas Haining; Werner Held; Patrick G Hogan; Axel Kallies; Enrico Lugli; Rachel C Lynn; Mary Philip; Anjana Rao; Nicholas P Restifo; Andrea Schietinger; Ton N Schumacher; Pamela L Schwartzberg; Arlene H Sharpe; Daniel E Speiser; E John Wherry; Benjamin A Youngblood; Dietmar Zehn
Journal:  Nat Rev Immunol       Date:  2019-09-30       Impact factor: 53.106

5.  Virus persistence in acutely infected immunocompetent mice by exhaustion of antiviral cytotoxic effector T cells.

Authors:  D Moskophidis; F Lechner; H Pircher; R M Zinkernagel
Journal:  Nature       Date:  1993-04-22       Impact factor: 49.962

6.  Deep immune profiling by mass cytometry links human T and NK cell differentiation and cytotoxic molecule expression patterns.

Authors:  Bertram Bengsch; Takuya Ohtani; Ramin Sedaghat Herati; Niels Bovenschen; Kyong-Mi Chang; E John Wherry
Journal:  J Immunol Methods       Date:  2017-03-19       Impact factor: 2.303

7.  Targeting mitochondrial dysfunction can restore antiviral activity of exhausted HBV-specific CD8 T cells in chronic hepatitis B.

Authors:  Paola Fisicaro; Valeria Barili; Barbara Montanini; Greta Acerbi; Manuela Ferracin; Francesca Guerrieri; Debora Salerno; Carolina Boni; Marco Massari; M Cristina Cavallo; Glenda Grossi; Tiziana Giuberti; Pietro Lampertico; Gabriele Missale; Massimo Levrero; Simone Ottonello; Carlo Ferrari
Journal:  Nat Med       Date:  2017-02-06       Impact factor: 53.440

8.  Network analysis reveals centrally connected genes and pathways involved in CD8+ T cell exhaustion versus memory.

Authors:  Travis A Doering; Alison Crawford; Jill M Angelosanto; Michael A Paley; Carly G Ziegler; E John Wherry
Journal:  Immunity       Date:  2012-11-15       Impact factor: 31.745

9.  Viral immune evasion due to persistence of activated T cells without effector function.

Authors:  A J Zajac; J N Blattman; K Murali-Krishna; D J Sourdive; M Suresh; J D Altman; R Ahmed
Journal:  J Exp Med       Date:  1998-12-21       Impact factor: 14.307

10.  Targeting p53 and histone methyltransferases restores exhausted CD8+ T cells in HCV infection.

Authors:  Valeria Barili; Paola Fisicaro; Barbara Montanini; Greta Acerbi; Anita Filippi; Giovanna Forleo; Chiara Romualdi; Manuela Ferracin; Francesca Guerrieri; Giuseppe Pedrazzi; Carolina Boni; Marzia Rossi; Andrea Vecchi; Amalia Penna; Alessandra Zecca; Cristina Mori; Alessandra Orlandini; Elisa Negri; Marco Pesci; Marco Massari; Gabriele Missale; Massimo Levrero; Simone Ottonello; Carlo Ferrari
Journal:  Nat Commun       Date:  2020-01-30       Impact factor: 14.919

View more
  30 in total

Review 1.  'Stem-like' precursors are the fount to sustain persistent CD8+ T cell responses.

Authors:  Dietmar Zehn; Robert Thimme; Enrico Lugli; Gustavo Pereira de Almeida; Annette Oxenius
Journal:  Nat Immunol       Date:  2022-05-27       Impact factor: 31.250

2.  PD-1 Immune Checkpoint Blockade and PSGL-1 Inhibition Synergize to Reinvigorate Exhausted T Cells.

Authors:  Karla M Viramontes; Emily N Neubert; Julia M DeRogatis; Roberto Tinoco
Journal:  Front Immunol       Date:  2022-06-14       Impact factor: 8.786

3.  Transcriptional Pattern Analysis of Virus-Specific CD8+ T Cells in Hepatitis C Infection: Increased Expression of TOX and Eomesodermin During and After Persistent Antigen Recognition.

Authors:  Nils H Wildner; Andreas Walker; Franziska Brauneck; Vanessa Ditt; Sven Peine; Samuel Huber; Friedrich Haag; Claudia Beisel; Joerg Timm; Julian Schulze Zur Wiesch
Journal:  Front Immunol       Date:  2022-06-06       Impact factor: 8.786

Review 4.  T cell responses during HBV and HCV infections: similar but not quite the same?

Authors:  Naglaa H Shoukry; Christopher M Walker
Journal:  Curr Opin Virol       Date:  2021-10-04       Impact factor: 7.121

Review 5.  A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection.

Authors:  Samaa T Gobran; Petronela Ancuta; Naglaa H Shoukry
Journal:  Front Immunol       Date:  2021-08-12       Impact factor: 7.561

6.  Epigenetic scars of CD8+ T cell exhaustion persist after cure of chronic infection in humans.

Authors:  W Nicholas Haining; Debattama R Sen; Kathleen B Yates; Pierre Tonnerre; Genevieve E Martin; Ulrike Gerdemann; Rose Al Abosy; Dawn E Comstock; Sarah A Weiss; David Wolski; Damien C Tully; Raymond T Chung; Todd M Allen; Arthur Y Kim; Sarah Fidler; Julie Fox; John Frater; Georg M Lauer
Journal:  Nat Immunol       Date:  2021-07-26       Impact factor: 25.606

7.  Identification of a T-bethi Quiescent Exhausted CD8 T Cell Subpopulation That Can Differentiate into TIM3+CX3CR1+ Effectors and Memory-like Cells.

Authors:  Saravanan Raju; Yu Xia; Bence Daniel; Kathryn E Yost; Elliot Bradshaw; Elena Tonc; Daniel J Verbaro; Kohei Kometani; Wayne M Yokoyama; Tomohiro Kurosaki; Ansuman T Satpathy; Takeshi Egawa
Journal:  J Immunol       Date:  2021-06-04       Impact factor: 5.426

Review 8.  Not-so-opposite ends of the spectrum: CD8+ T cell dysfunction across chronic infection, cancer and autoimmunity.

Authors:  Jenna L Collier; Sarah A Weiss; Kristen E Pauken; Debattama R Sen; Arlene H Sharpe
Journal:  Nat Immunol       Date:  2021-06-17       Impact factor: 31.250

Review 9.  CD8+ T Cell Responses during HCV Infection and HCC.

Authors:  Maike Hofmann; Catrin Tauber; Nina Hensel; Robert Thimme
Journal:  J Clin Med       Date:  2021-03-02       Impact factor: 4.241

Review 10.  Hepatitis D virus in 2021: virology, immunology and new treatment approaches for a difficult-to-treat disease.

Authors:  Stephan Urban; Christoph Neumann-Haefelin; Pietro Lampertico
Journal:  Gut       Date:  2021-06-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.